Value proposition

Multiorgan support for rare pediatric and acute liver diseases


Versantis is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to revolutionize the care of patients with liver and rare pediatric diseases. We address the unmet medical needs in emergency care. Our mission is to support acute decompensations of cirrhosis and to save infants born with rare genetic disorders.

Hepatology, Hyperammonemia, Metabolic disease, Liver diseases, and Gastroenterology